LEADER 01307nas  2200433-a 450 
001 9910144182203321
005 20241221110045.0
011   $a1744-8301
035   $a(CKB)1000000000220631
035   $a(CONSER)--2005244028
035   $a(MiFhGG)3GMP
035   $a(EXLCZ)991000000000220631
100   $a20050906a20059999  ---         -
101 0 $aeng
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aFuture oncology
210   $aLondon $cFuture Medicine Ltd.$dİ2005-
210 31$a[Milton Park, Oxfordshire] :$cTaylor & Francis
215   $a1 online resource
300   $aRefereed/Peer-reviewed
300   $aTitle from cover.
311 08$aPrint version: Future oncology (London, England) (DLC)  2005244028 (OCoLC)62416786 1479-6694 
531   $aFUTURE ONCOL
531 10$aFuture Oncol
606   $aCancer$xTreatment$vPeriodicals
606   $aCancer$xTreatment$2fast$3(OCoLC)fst00845538
606   $aNeoplasms$xtherapy
608   $aPeriodicals.$2fast
608   $aPeriodical.
615  0$aCancer$xTreatment
615  7$aCancer$xTreatment.
615 12$aNeoplasms$xtherapy.
906   $aJOURNAL
912   $a9910144182203321
920   $aexl_impl conversion
996   $aFuture oncology$92125697
997   $aUNINA